Filing Details

Accession Number:
0001479290-20-000110
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-02 20:55:29
Reporting Period:
2020-11-30
Accepted Time:
2020-12-02 20:55:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1479290 Revance Therapeutics Inc. RVNC Pharmaceutical Preparations (2834) 770551645
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1818576 Aubrey Rankin C/O Revance Therapeutics, Inc
7555 Gateway Blvd
Newark CA 94560
President, Innovation & Tech Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-11-30 33,119 $23.85 510,684 No 4 S Indirect Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 174,302 Indirect The Rankin Irrevocable Trust
Common Stock 67,871 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Rankin.
  2. The price reported in Table 1, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.61 to $24.54. Mr. Rankin undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. These shares are held by the Aubrey and Luanne Rankin Revocable Living Trust dated July 1, 2009. Mr. Rankin is a Trustee of this Trust.
  4. These shares are held by The Rankin Irrevocable Trust. Mr. Rankin is a Trustee of the Rankin Irrevocable Trust.